Study Links Nexavar To Hypertension Risk

Law360, New York (January 23, 2008, 12:00 AM EST) -- A new study is warning about the potential side effects of Nexavar, maintaining that the drug used to treat kidney and liver cancer can trigger a significant spike in blood pressure.

On Tuesday, the medical journal Lancet Oncology published a study on the effects of the chemotherapy drug, also known by the scientific name sorafenib, with the authors urging patients currently taking Nexavar to remain under close watch due to a potential link with hypertension.

The U.S. Food and Drug Administration approved the drug in 2005...
To view the full article, register now.